Kathleen Chapman Degen, M.D.
Hematology & Oncology Physician · Wynnewood, PA
Kathleen Chapman Degen, M.D. is a hematology & oncology physician with a practice address in Wynnewood, Pennsylvania, and NPI 1679952493, issued on May 26, 2015. Check the license (Pennsylvania MT208987, as entered in NPPES) on the Pennsylvania Department of State (PALS); the Medicare figures below come from public CMS files.
- Name
- Kathleen Chapman Degen
- Credential
- M.D.
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License numbers
- MT208987 PA
MD465699 PA
Self-reported in NPPES; status is on the state search - Practice location
- 100 E Lancaster Ave Ste G44, Wynnewood, PA 19096
- Phone
- (484) 476-4672
- Enumerated
- May 26, 2015
- Record last updated
- May 6, 2022
- Fax
- (484) 476-5829
- Medicare enrollment
- Enrolled (PECOS I20181016002057); accepts Medicare assignment
- Telehealth
- Offers telehealth (CMS)
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 784 in Pennsylvania → Look up another NPI →
Verify Kathleen Chapman Degen in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersPennsylvania Department of State (PALS)
Search for license MT208987Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
4% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
845 Medicare Part D claims for 147 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. 57 claims were for opioids.
Most prescribed
- Eliquis137 claims
- Anastrozole117 claims
- Prochlorperazine Maleate44 claims
- Acyclovir43 claims
- Xarelto36 claims
- Prednisone31 claims
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
Industry payments in 2024: $1,774.51
19 payments; by number, the most common kind was food and beverage; the largest payer was Genzyme Corporation. The 8,560 providers of this specialty with any payment received $7,481.41 on average. Payments are reported by manufacturers, not by the provider, and are not a sign of wrongdoing.
Source: CMS Open Payments, program year 2024 (openpaymentsdata.cms.gov); average among providers of this specialty with at least one payment.
Bills Medicare through one group practice
- Aria Health Physician ServicesPhiladelphia, PA
Source: CMS Doctors and Clinicians National Downloadable File (the group practices a clinician bills Medicare through) (data.cms.gov).
Kathleen Chapman Degen among 784 hematology & oncology physician records in Pennsylvania
Kathleen Chapman Degen, M.D. is one of 784 hematology & oncology physician records with a practice address in Pennsylvania. 83% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2015, is newer than 78% of them.
- NPI issued2015 · 78% of these records are older, 18% newer
- In a Medicare fileYes · 83% of these records are
- In the CMS Doctors and Clinicians fileYes · 71% of these records are
- Graduated2015 · median 2004 among the 553 with a school on file
- Record last updated2022 · 60% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Pennsylvania practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Pennsylvania
There are 784 hematology & oncology physician records in Pennsylvania.
All 784 in Pennsylvania → Every provider in Wynnewood → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Zonera Ali, MDWynnewood, PA 190961306852728
- Arezoo Ghaneie, MDWynnewood, PA 190961790853497
- Paul Gilman, MDWynnewood, PA 190961215943634
- David Harris, MDWynnewood, PA 190961871584169
- Tamer Khashab, M.D.Wynnewood, PA 190961336502723
- Peter LebowitzWynnewood, PA 190961942200860
- Theresa McHugh, DOWynnewood, PA 190961053321059
- Clifford PembertonWynnewood, PA 190961770592792
Common questions
What is Kathleen Chapman Degen, M.D.'s NPI number?
Kathleen Chapman Degen, M.D.'s National Provider Identifier (NPI) is 1679952493, issued on May 26, 2015. An NPI identifies a provider in billing; it is not a license.
Where is Kathleen Chapman Degen, M.D. located?
The NPPES record lists a practice address at 100 E Lancaster Ave Ste G44, Wynnewood, PA, 19096. Phone: (484) 476-4672. Providers update this record themselves, so call before visiting.
How can I verify Kathleen Chapman Degen, M.D.'s license?
NPPES lists Pennsylvania license number MT208987, as entered by the provider. Search the Pennsylvania Department of State (PALS) at https://www.pals.pa.gov/. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Kathleen Chapman Degen, M.D. prescribe under Medicare Part D?
In 2024, Kathleen Chapman Degen, M.D. had 845 Medicare Part D claims for 147 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.